3-Month Discontinuation of Dual Antiplatelet Therapy after Ultimaster Sirolimus-Eluting Stent Implantation
Phase of Trial: Phase III
Latest Information Update: 12 Sep 2017
At a glance
- Drugs Sirolimus (Primary)
- Indications Coronary artery disease
- Focus Therapeutic Use
- Acronyms MODEL U-SES
- 12 Sep 2017 Last checked against University Hospital Medical Information Network - Japan record.
- 07 Nov 2016 Status changed from not yet recruiting to recruiting.
- 21 Jul 2016 New trial record